SonoSite to Present at Two Investor Conferences in September

Northwest Medical Device & Biotechnology Forum and UBS Global Life Sciences Conference BOTHELL, WA - September 14, 2005 - SonoSite, Inc. (NASDAQ: SONO), the world leader in hand-carried ultrasound, today announced that Mike Schuh, Chief Financial Officer, and Anne Bugge, Vice President of Corporate Affairs, will present at the Northwest Medical Device & Biotechnology Investor Forum at 10:00 a.m.

(ET) on Tuesday, September 20, 2005 at the Harvard Club of New York City. The forum is hosted by Delafield Hambrecht and WBBA. SonoSite also announced that Kevin M. Goodwin, President and CEO, will present at the 2005 UBS Global Life Sciences Conference at 12:30 p.m. (ET) on Wednesday, September 28 at the Grand Hyatt Hotel in New York City. Investors can access an audio-webcast of Mr. Goodwin's presentation on SonoSite's website. The webcast will be available beginning September 28, 2005, until 3:30 p.m. (ET) October 29, 2005.

About SonoSite
Headquartered near Seattle, Washington, SonoSite ( is represented by seven subsidiaries and a global distribution network in over 75 countries. SonoSite's small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high performance ultrasound to the point of patient care. The company employs approximately 450 people worldwide.